• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • FAQ
  • HGRAC

FAQ


  • FAQ
  • Active Device
  • Non-active Device
  • IVD
  • HGRAC
  • Clinical Evaluation
  • Common FAQ
  • Is It Necessary To Apply For HGR Collection Permission If Only Collecting Clinical Data?

    If only collecting clinical image data (such as B-mode ultrasound, CT, PET-CT, nuclear magnetic resonance, X-ray and other image data, intervention, fundus, endoscope, dermatoscope, pathological diagnosis and other image data), clinical data that does not involve population gene research (such as blood routine, urine routine, liver and kidney function, blood biochemistry and other general laboratory examination information, height, weight and other growth and development indicators, questionnaire information, imaging / image result data, etc.), There is no need to apply for approval of human genetic resources collection license.

    READ MORE >

  • NMPA Technical Review And Approval Procedure Of Medical Devices–Others

    1. Re-issuance of registration certificate

    (1). A registrant may, free of charge, apply for re-issuance of the registration certificate and/or its attachments and registration documents of the modifications within the valid period of the Medical Device/IVD Reagent Registration Certificate/registration documents of the modifications.

    (2). Handling process

    The registrant shall submit relevant application to the Administrative Service Hall of the National Medical Products Administration.

    Application dossiers that meet the formal examination requirements will be accepted and then transferred to the Department of Medical Device Registration.

    The staff of the Department of Medical Device Registration shall offer the examination opinions within 10 working days upon receiving the application dossiers, and the person-in-charge of the division will give his/her review opinions within 4 working days and feedback to the Administrative Service Hall.

    The Administrative Service Hall will produce documents according to corresponding opinions within 10 working days, and perform service procedures as required.

    ...

    READ MORE >

  • NMPA Supplementary

    1. Definition of Supplementary

    When the registration information can not meet relevant requirement or need additional information during evaluation, reviewers will issue a "Deficiency Letter" to the applicant collectively requesting the information needed at one time.

    2. Way of Supplementary

    (1). Online Mode

    Issue the "Deficiency Letter" to the applicant/registrant through the eRPS system, mail the print edition of the "Deficiency Letter" at the same time.

    (2). Offline Mode

    Mail the printed "Deficiency Letter" to the applicant/registrant.

    3. Requirement of Supplementary

    Applicant/Registrant should complete the submission of the supplementary information within one year, according to the "Deficiency Letter" strictly.

    4. Delivery

    (1). Online Mode

    Applicant/Registrant can submit the supplementary documents through “supplementary” module in eRPS system.

    -->

    ...

    READ MORE >

  • NMPA Review And Approval

    1. Functions of the CMDE

    Evaluation of domestic Class III and imported medical devices.

    Administrative approval for change of licensing matters and registration renewal of domestic Class III and imported medical devices.

    Approval decisions on clinical trials on Class III medical devices with high risks.

    2. Registration Application Flowchart

    3. Evaluation timeframe

    90 working days for Class III medical devices.

    60 working days for Class II medical devices.

    One year for deficiency submission (excluded from evaluation timeframe).

    60 working days for evaluation after response.

    4. Query for evaluation and approval The progress of evaluation and approval can be queried via t

    ...

    READ MORE >

  • NMPA Renewal

    1. A medical device registration certificate is valid for 5 years. According to national regulations, applicants/registrants shall apply for registration renewal no later than 6 months prior to the certificate expiry date. However, the registration renewal shall not be granted under any of the following circumstances:

    (1). The applicants/registrant fails to submit the application within the prescribed time limit.

    (2). The mandatory standards for medical devices have been revised, and the product fails to meet the new requirements.

    (3). For medical devices required for the treatment of rare diseases or urgently needed to respond to public health emergencies, the items specified in the Medical Device Registration Certificate have not been completed within the prescribed time limit.

    2. Handling process

    (1). The certificate issuing authority is in charge of processing the applications for registration renewal.

    (2). The Administrative Service Hall will transfer the application dossiers that pass formal examination to the Center for Medical Device Evaluation.

    (3). The Center for Medical Device

    ...

    READ MORE >

  • NMPA Rejected Registration And Initiative Revocation Of Registration Application

    1.Rejected registration

    (1). Interpretation on "Rejected Registration"

    After the technical evaluation and/or administrative approval, the devices shall not be allowed for registration, if the application for registration of medical devices is deemed as unable to prove the safety, effectiveness or non-compliance with the requirements of laws and regulations.

    (2). Common circumstances of rejected registration

    Application dossiers for registration are false.

    The contents of application dossiers for registration are disordered or confusing.

    The contents of application dossiers for registration are obviously inconsistent with the application matters.

    The project for registration application does not involve a medical device.

    The applicant does not apply in accordance with the prescribed registration form.

    The registration quality management system inspection result is that the medical device fails to pass verification after inspection or rectification.

    ...

    READ MORE >

  • NMPA Priority Evaluation And Approval Processes

    1. The benefits of priority review and approval

    Getting priority for quality management system inspection.

    Getting priority on the waiting list for evaluation and approval.

    Getting special channel for communication.

    2. Conditions for application

    The National Medical Products Administration implements the priority evaluation and approval policy for registration of domestic medical devices of Class III and imported medical devices of Classes II and III which meet one of the following conditions:

    (1). The medical devices which satisfy one of the following conditions:

    The medical devices for diagnosis or treatment of rare diseases and with obvious clinical advantages.

    The medical devices for diagnosis or treatment of malignant tumors and with obvious clinical advantages.

    The medical devices for diagnosis or treatment of diseases which are endemic to and prevalent in the elderly and against which the existent diagnosis or treatment approaches have been ineffective.

    ...

    READ MORE >

  • NMPA Notification On Instruction For Use Changes

    1. Notification on IFU Changes

    For approved medical devices, Notification of IFU Changes refers to the process that the registration authority will, after the IFU is modified upon approval, notify the Department of Medical Device Registration, NMPA or provincial Medical Administration Department that the changes, excluding the content in the Medical Device Registration Certificate and its attachments are approved.

    2. Three review results

    Approve

    Partially approve

    Disapprove

    3. Application procedures

    Online(eRPS system):The applicant/registrant submits the application dossiers through eRPS system.

    Offline: An applicant/registrant shall make an application to the National Medical Products Administration according to the requirements for application dossiers of Notification on IFU Changes.

                        
                    <!-- -->

    ...

    READ MORE >

  • NMPA Issuing Of Certificates

    After the National Medical Products Administration makes a decision on approval, applicant/registrant shall receive their registration certificates for medical devices according to relevant regulations.

    1. Query the progress of certificate production

    Log in the website of National Medical Products Administration.

    Click "Query for Comprehensive Administrative Licensing Matters".

    Click "Query for The Schedule of Medical devices Registration".

    The applicant/registrant can acquisition the certificate if the system displays "Completed - to be received”.

    2. Ways of certificate claiming

    (1). Way 1: On-site claiming

    applicant/registrant can get their certificates at the  Administrative Service Hall of NMPA within 3 working days after the production of certificates is completed.

    To claim the certificate, the agent shall provide his/her letter of authorization and the original and photocopy of his/her identity certificate.

    Address:1 / f

    ...

    READ MORE >

  • NMPA Innovative Medical Device Review And Emergency Review

    Ⅰ.Innovative Medical Device Review

    1. The significance of the Special Evaluation and Approval Procedure for Innovative Medical Devices (IMD)

    (1). To encourage the research and innovation on medical devices

    (2). To facilitate the promotion and application of new technologies in medical devices

    (3). To accelerate the development of medical device industry

    2. The requirements for the application of Special Evaluation and Approval Procedure for IMD

    (1). There are three prerequisites:

    Through their predominant technological innovation research, the applicants/registrant legally own the patent right of the product core technology invention in China.

    The applicants/registrant can obtain the invention patent or use rightin China by legal transfer.

    The application for the core technology invention patent has been disclosed by the Patent Administration Department.

    (2). The main working principle or action mechanism of the product is the firs

    ...

    READ MORE >

  • NMPA Expert Consultation Meeting

    1. Expert consultation meeting

    Expert consultation meeting refers to the process in which the Center for Medical Device Evaluation of NMPA will invite consultancy experts (hereinafter referred to as “Experts”) to discuss the technical problems to be consulted and offer opinions during its evaluation work for medical device registration.

    2. Circumstances in which an expert consultation meeting may be convened

    The medical devices that have passed innovation approval.

    The medical devices that have passed priority approval.

    The medical devices that have passed expedited approval.

    The medical devices that are firstly registered among the predicate products.

    Technical subcommittees shall respectively resolve the technical problems of other products identified during evaluation. Disputes may be submitted to the Center's Technical Committee for discussion. When it is necessary to consult experts, the technical subcommittee may apply for convening an expert consultation meeting upon the approval of the Center's Technical Committee.

    3. Relevant

    ...

    READ MORE >

  • NMPA Consultation After Supplementary

    1. The Scope of Consultation after Supplementary

    This consultation is mainly for medical device registration items that are in the state of being supplemented. Before the submission of supplementary documents, applicant/registrant can communicate with reviewer about questions of "Deficiency Letter".

    2. Way of consultation

    On-site consultation (every Thursday).

    Online consultation (online Q&A in 20 working days).

    Common questions on CMDE website.

    Pre-evaluate for supplementary documents.

    3. Reservation for consultation after supplementary

    Log in the Technical Review Consulting Platform and click "Ordinary Product Consultation”.

    Reserve "On-site Consultation” or "Online Consultation".

    4. The process of Consultation after Supplementary

    (1). On-site consultation

    The on-site consultation shall be in principle scheduled at 9:00am

    ...

    READ MORE >

« Prev...246...2122232425...28...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7